|
Market Closed -
Other stock markets
|
After hours 03:00:00 | |||
| 79.77 USD | -2.48% |
|
70.89 | -11.13% |
| 07-07 | Moderna, TG Therapeutics, Agios Pharmaceuticals Q2 Results May Face Increased Scrutiny, BofA Says | MT |
| 07-07 | BofA Adjusts Price Target on Moderna to $38 From $34, Maintains Underperform Rating | MT |
| Market Cap | 31.65B 27.7B 25.53B 23.66B 44.91B 3,004B 45.64B 306B 119B 1,483B 119B 116B 5,124B | P/E 2026 * |
-9.21x | P/E 2027 * | -16.8x |
|---|---|---|---|---|---|
| Enterprise Value | 28.05B 24.54B 22.62B 20.96B 39.8B 2,662B 40.44B 271B 105B 1,314B 105B 103B 4,541B | EV / Sales 2026 * |
13.4x | EV / Sales 2027 * | 11.5x |
| Free-Float |
92.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Moderna, Inc.
| 1 day | -2.48% | ||
| 1 week | +13.91% | ||
| Current month | +13.91% | ||
| 1 month | +68.15% | ||
| 3 months | +59.19% | ||
| 6 months | +122.26% | ||
| Current year | +170.50% |
| 1 week | 73.68 |  | 85.6 |
| 1 month | 45.4 | | 85.6 |
| Current year | 29.81 | | 85.6 |
| 1 year | 22.28 | | 85.6 |
| 3 years | 22.28 | | 170.47 |
| 5 years | 22.28 | | 497.49 |
| 10 years | 11.54 | | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 01/03/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 06/09/2022 |
Stephen Hoge
PSD | President | 50 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 01/02/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 01/03/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 11/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-02 | Fiscal year | Chief Financial Officer | 3,607 | 0.0009% | ||
| 06-15 | Fiscal year | Chairperson | 160,008 | 0.0403% | ||
| 06-05 | Fiscal year | Chief Financial Officer | 29,301 | 0.0074% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.48% | +13.91% | +166.79% | -32.89% | 31.65B | |
| +4.07% | +8.45% | +25.67% | -2.34% | 68.8B | |
| -1.26% | -2.83% | +47.33% | +219.48% | 55.21B | |
| +1.21% | +42.20% | +42.20% | +42.20% | 43.46B | |
| +0.27% | +8.33% | -49.87% | -53.43% | 41.18B | |
| -1.32% | -4.79% | +58.07% | -25.22% | 30.37B | |
| +2.10% | +4.14% | +75.49% | +90.19% | 23.58B | |
| -1.20% | +8.10% | +4.24% | +184.46% | 19.33B | |
| -1.65% | +2.34% | +65.31% | +132.45% | 17.16B | |
| +0.21% | +4.61% | +79.10% | +361.28% | 15.27B | |
| Average | -0.02% | +4.32% | +51.43% | +91.62% | 34.6B | |
| Weighted average by Cap. | +0.45% | +4.21% | +44.49% | +67.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.09B 1.83B 1.69B 1.56B 2.97B 198B 3.01B 20.22B 7.86B 97.94B 7.85B 7.68B 339B | 2.54B 2.23B 2.05B 1.9B 3.61B 241B 3.67B 24.61B 9.57B 119B 9.55B 9.35B 412B |
| Net income | -3.41B -2.98B -2.75B -2.55B -4.84B -324B -4.92B -32.98B -12.83B -160B -12.8B -12.53B -552B | -1.85B -1.62B -1.49B -1.38B -2.63B -176B -2.67B -17.89B -6.96B -86.66B -6.95B -6.8B -300B |
| Net Debt | -3.61B -3.16B -2.91B -2.7B -5.12B -342B -5.2B -34.87B -13.56B -169B -13.54B -13.24B -584B | -2.27B -1.99B -1.83B -1.7B -3.23B -216B -3.28B -22B -8.56B -107B -8.54B -8.36B -368B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | $79.77 | -2.48% | 8,688,340 |
| 06/07/26 | $81.80 | +2.56% | 17,296,875 |
| 02/07/26 | $79.76 | +10.01% | 14,111,998 |
| 01/07/26 | $72.50 | +3.53% | 9,275,292 |
| 30/06/26 | $70.03 | +0.47% | 11,805,910 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
